Thyrocare Technologies Limited
Stock Forecast, Prediction & Price Target
Thyrocare Technologies Limited Financial Estimates
Thyrocare Technologies Limited Revenue Estimates
Thyrocare Technologies Limited EBITDA Estimates
Thyrocare Technologies Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| ₹4.94B N/A | ₹5.88B 19.05% | ₹5.71B -2.88% | Avg: ₹7.54B Low: ₹7.54B High: ₹7.54B avg. 31.86% | |||
Net Income
% change YoY
| ₹1.13B N/A | ₹1.76B 55.66% | ₹707.6M -59.82% | Avg: ₹1.19B Low: ₹1.19B High: ₹1.19B avg. 69.52% | |||
EBITDA
% change YoY
| ₹1.83B N/A | ₹2.37B 29.14% | ₹1.48B -37.55% | Avg: ₹2.48B Low: ₹2.48B High: ₹2.48B avg. 67.73% | |||
EPS
% change YoY
| $21.41 N/A | $33.3 55.53% | $13.42 -59.69% | Avg: $22.75 Low: $22.75 High: $22.75 avg. 69.52% | |||
Operating Expenses
% change YoY
| ₹1.89B N/A | ₹2.18B 15.06% | ₹1.59B -26.70% | Avg: ₹891.40M Low: ₹891.40M High: ₹891.40M avg. -44.24% | |||
FAQ
What is Thyrocare Technologies Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 69.52% in 2026-2026.
We have gathered data from N/A analysts. Their low estimate is 1.19B, average is 1.19B and high is 1.19B.
What is Thyrocare Technologies Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 31.86% in 2026-2026.
We have gathered data from N/A analysts. Their low revenue estimate is ₹7.54B, average is ₹7.54B and high is ₹7.54B.
What is Thyrocare Technologies Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 69.52% in 2026-2026.
We have gathered data from N/A analysts. Their low earnings per share estimate is $22.75, average is $22.75 and high is ₹22.75.